ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Emergex signs agreement with George Mason University for highly pathogenic RNA virus studies
April 24, 2020Emergex Vaccines Holding, a biotechnology company developing CD8+ priming set-point vaccines to prevent serious infectious diseases, announced that it has entered into an agreement with the George Mason University, based in Virginia, in the United States.
Pharma Sources Insight January 2025
